trials – Page 2

Lilly’s Weekly Insulin Therapy Excels in Two Major Clinical Trials, Narrowing Gap with Novo Nordisk

2 years ago talkbio0Tagged Administration occupational activities, Clinical Trials, Diabetes, Drug Industry, Eli Lilly, Insulin, insulin therapy, Nordisk, Primary Endpoint, trials, Weekly

Lilly, Novo Nordisk, weekly insulin, primary endpoint, pivotal trials, diabetes management, insulin therapy, clinical trials, diabetes treatment, pharmaceutical industry.

Zenas Biotech Secures $200 Million for Advancing Obexelimab in Pivotal Immunology Trials

2 years ago talkbio0Tagged Autoimmune Diseases, B-cell-directed therapy, Biotechnology, Drug Development, Immunology, Obexelimab, trials, Zenas Biotech

Zenas Biotech, obexelimab, immunology trials, funding, biotechnology, drug development, autoimmune diseases, B-cell-directed therapy.

Eli Lilly’s Zepbound Shows Promising Results in Reducing Sleep Apnea Severity in Pivotal Trials

2 years ago talkbio0Tagged Continuous Positive Airway Pressure, Eli, Eli Lilly, Glucagon-Like Peptide-1 Receptor, Obesity, Sleep Apnea, Obstructive, tirzepatide, trials, Weight Loss, Zepbound

Eli Lilly, Zepbound, Sleep Apnea, Obstructive Sleep Apnea (OSA), Pivotal Trials, Obesity, GLP-1 Receptor Agonist, Tirzepatide, CPAP, Weight Loss